SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-045360
Filing Date
2023-06-02
Accepted
2023-06-02 06:02:40
Documents
14
Period of Report
2023-05-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea179668-8k_adialpharm.htm   iXBRL 8-K 40767
2 PURCHASE AGREEMENT, DATED AS OF MAY 31, 2023, BY AND BETWEEN ADIAL PHARMACEUTICA ea179668ex10-1_adialpharm.htm EX-10.1 155883
  Complete submission text file 0001213900-23-045360.txt   454322

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE adil-20230531.xsd EX-101.SCH 3470
4 XBRL DEFINITION FILE adil-20230531_def.xml EX-101.DEF 26540
5 XBRL LABEL FILE adil-20230531_lab.xml EX-101.LAB 36424
6 XBRL PRESENTATION FILE adil-20230531_pre.xml EX-101.PRE 25164
8 EXTRACTED XBRL INSTANCE DOCUMENT ea179668-8k_adialpharm_htm.xml XML 5267
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38323 | Film No.: 23986652
SIC: 2834 Pharmaceutical Preparations